 Variants of PCSK9 can reduce or increase circulating cholesterol.LDL-particles are removed from the blood when they bind to LDLR on the surface of cells, including liver cells, and are taken inside the cells.When PCSK9 binds to an LDLR, the receptor is destroyed along with the LDL particle.